SCOPUS 정보 검색 플랫폼

Antiviral Research

Volumn 77, Issue 1, 2008, Pages 1-5

Discovery and development of antiviral drugs for biodefense: Experience of a small biotechnology company

(2) Bolken, Tove C a Hruby, Dennis E a

a SIGA Technologies Incorporated (United States)

Author keywords

Antiviral; Biothreat agents; Category A; Drug development; Hemorrhagic fever virus; Smallpox

Indexed keywords

ANTIVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; RNA; ST 246; UNCLASSIFIED DRUG;

ANTIVIRAL THERAPY; BIOLOGICAL WARFARE; BIOTECHNOLOGY; CLINICAL TRIAL; DRUG EFFICACY; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; HEALTH CARE ORGANIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LICENSING; PRIORITY JOURNAL; PRIVATE PRACTICE; REVIEW; SMALLPOX; VIRUS INFECTION;

ANIMALS; ANTIVIRAL AGENTS; BENZAMIDES; BIOTECHNOLOGY; BIOTERRORISM; CLINICAL TRIALS AS TOPIC; DRUG APPROVAL; DRUG DESIGN; DRUG INDUSTRY; HUMANS; ISOINDOLES; MODELS, ANIMAL; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

VARIOLA VIRUS;

EID: 37449019276 PISSN: 01663542 EISSN: None Source Type: Journal
DOI: 10.1016/j.antiviral.2007.07.003 Document Type: Review

Times cited : (20)

References (3)

1
- 33846623695
- Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in mice
- Quenelle D.C., Buller R.M., Parker S., Keith K.A., Hruby D.E., Jordan R., and Kern E.R. Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in mice. Antimicrob. Agents Chemother. 51 (2007) 689-695
- (2007) Antimicrob. Agents Chemother. , vol.51 , pp. 689-695
- Quenelle, D.C.¹ Buller, R.M.² Parker, S.³ Keith, K.A.⁴ Hruby, D.E.⁵ Jordan, R.⁶ Kern, E.R.⁷

2
- 34249742507
- Efficacy of the antipoxvirus compound ST-246 for treatment of severe orthopoxvirus infection
- Sbrana E., Jordan R., Hruby D.E., Mateo R.I., Xiao S.Y., Siirin M., Newman P.C., AP D.A.R., and Tesh R.B. Efficacy of the antipoxvirus compound ST-246 for treatment of severe orthopoxvirus infection. Am. J. Trop. Med. Hyg. 76 (2007) 768-773
- (2007) Am. J. Trop. Med. Hyg. , vol.76 , pp. 768-773
- Sbrana, E.¹ Jordan, R.² Hruby, D.E.³ Mateo, R.I.⁴ Xiao, S.Y.⁵ Siirin, M.⁶ Newman, P.C.⁷ AP, D.A.R.⁸ Tesh, R.B.⁹

3
- 26444587116
- An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge
- Yang G., Pevear D.C., Davies M.H., Collett M.S., Bailey T., Rippen S., Barone L., Burns C., Rhodes G., Tohan S., Huggins J.W., Baker R.O., Buller R.L., Touchette E., Waller K., Schriewer J., Neyts J., DeClercq E., Jones K., Hruby D., and Jordan R. An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge. J. Virol. 79 (2005) 13139-13149
- (2005) J. Virol. , vol.79 , pp. 13139-13149
- Yang, G.¹ Pevear, D.C.² Davies, M.H.³ Collett, M.S.⁴ Bailey, T.⁵ Rippen, S.⁶ Barone, L.⁷ Burns, C.⁸ Rhodes, G.⁹ Tohan, S.¹⁰ Huggins, J.W.¹¹ Baker, R.O.¹² Buller, R.L.¹³ Touchette, E.¹⁴ Waller, K.¹⁵ Schriewer, J.¹⁶ Neyts, J.¹⁷ DeClercq, E.¹⁸ Jones, K.¹⁹ Hruby, D.²⁰ Jordan, R.²¹ more..

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.